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ABSTRACT
Chromosomal rearrangement (CR) events result
from abnormal breaking and rejoining of the DNA
molecules, or from crossing-over between repetitive
DNAsequences, andtheyareinvolved inmanytumor
and non-tumor diseases. Investigations of disease-
associated CR events can not only lead to important
discoveries about DNA breakage and repair mech-
anisms, but also offer important clues about the
pathologic causes and the diagnostic/therapeutic
targets of these diseases. We have developed
a database of Chromosomal Rearrangements In
Diseases (dbCRID, http://dbCRID.biolead.org), a
comprehensive database of human CR events and
their associated diseases. For each reported CR
event, dbCRID documents the type of the event, the
disease or symptoms associated, and—when
possible—detailed information about the CR event
including precise breakpoint positions, junction
sequences, genes and gene regions disrupted
and experimental techniques applied to discover/
analyze the CR event. With 2643 records of
disease-associated CR events curated from 1172
original studies, dbCRID is a comprehensive and
dynamic resource useful for studying DNA
breakage and repair mechanisms, and for analyzing
the genetic basis of human tumor and non-tumor
diseases.
INTRODUCTION
A chromosomal rearrangement (CR) event occurs as a
consequence of double-strand breaks (DSBs) of the
DNA, followed by abnormal rejoining of the non-
homologous ends, producing a new chromosomal
arrangement (1). Alternatively, a CR event can result
from crossing-over between repetitive DNA sequences
(2). CR events may lead to disruption of genes and other
functional structures. They have been implicated in many
tumor and non-tumor human diseases (3,4), and are
frequently examined in clinical diagnosis, treatment and
prognosis (5–7). Analyses of junction sequences at CR
breakpoints have lead to the discovery of multiple short
sequence motifs, including polypurine/polypyrimidine
sequences (8), Ig heptamers (9), translin-binding sites (10)
and minisatellite core sequences (11). These sequence
motifs may play important roles in DNA breakage and
repair mechanisms (12). CR events can be categorized
into the following seven types: deletion, duplication, inser-
tion, inversion, reciprocal translocation, ring chromosome
and translocation.
Cytogenetics techniques commonly applied to identify
and analyze CR events include high-resolution chromo-
some banding (13), ﬂuorescence in situ hybridization
(FISH) (14), spectral karyotyping (SKY) (15), compara-
tive genomic hybridization (CGH) (16), and polymerase
chain reaction (PCR). In recent years, advances in DNA
sequencing technologies and the completion of the human
genome have led to accelerated accumulation of experi-
mentally identiﬁed CR events. Information about CR
events and their associated diseases and/or clinical
symptoms can provide important clues about the chromo-
somal breakage and DNA repair mechanisms. Moreover,
this information, if fully exploited, can bring about
improved understanding about how CR events lead to
these important diseases, as well as how other factors
(e.g. features in junction sequences) inﬂuence their occur-
rence and progression, which in turn will lead to improved
prevention of and clinical intervention for these diseases.
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dbCRID, a manually curated database of human CR
events and their associated diseases. dbCRID includes
2643 individually curated entries of experimentally tested
CR events, their associated diseases and/or clinical
symptoms and detailed information about the CR events,
including the precise locations of the breakpoints, genes
involved, junction sequences, as well as the experimental
techniques applied, and links to the original studies.
Curated from 1172 original studies, dbCRID is a compre-
hensive resource of human CR events, breakpoints/
junctions and associated diseases.
UTILITY
Data content
All data were manually extracted from original, peer-
reviewed published studies about CR events and
associated human diseases. A consistent procedure was
established to identify studies likely to contain useful
data by examining the abstracts and full-text articles
through the PubMed database. For each reported CR
event, we documented the CR type, breakpoint informa-
tion, junction sequences, genes involved in the CR event,
names of the diseases (tumor or non-tumor) and/or
clinical symptoms, as well as the experimental technique
applied in the study. The breakpoint information includes
the position of the breakpoint, disrupted gene (when avail-
able) and gene region (which exon or intron), as well as a
‘precision code’, which describes the level of precision
determined for the breakpoint. The precision code ‘A’ in-
dicates that the CR event is determined at the highest
precision—to an individual nucleotide level. Precision
code ‘B’ indicates that the CR event is determined to
an individual gene level. Precision code ‘C’ indicates the
lowest precision: the breakpoints of CR events with
precision code ‘C’ can only be localized to a broad
region within a chromosome.
For all events with precision code ‘A’, the exact break-
point positions were consistently mapped to the human
genome hg19 (NCBI Build 37.1 Feb 2009). For events
with precision code ‘A’ or ‘B’, the chromosomal locations
of the breakpoints (e.g. 2p24.1) and precise locations of
involved genes (consistently identiﬁed using RefSeq acces-
sions) were mapped to the same build of the human
genome using the Ensembl BLAST tool (17).
Junction sequences at CR breakpoints may provide
important clues as of how the CR events occurred (18),
and analyses of these junction sequences have led to
interesting discoveries about the DNA repair mechanisms
(19). We have carefully documented the junction
sequences, whenever possible. Frequently, the junction
sequence discovered in the original study does not per-
fectly match the joining of the two non-homologous
sequences prior to the CR event. We labeled these
junction sequences as ‘reported’ in dbCRID. If the
junction sequence discovered is the same as the joining
of the non-homologous sequences, we labeled it as ‘con-
ﬁrmed’. For certain CR events with precision code ‘A’, the
junction sequences were not explicitly provided in the
original study. We inferred the junction sequences by
joining 100nt from both sides of the junction following
the CR events, and labeled these junction sequences as
‘inferred’.
The current release of dbCRID hosts the records of 2643
CR events curated from 1172 original studies. Detailed
statistics of the records is summarized in Figure 1.
Figure 1. Statistical summaries of CR events documented in dbCRID. (a) Summary of CR types. (b) Summary for breakpoint precisions. (c)
Summary for disease categories. (d) Summary for junction sequence types.
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The web interface of dbCRID database can be accessed
through the URL http://dbCRID.biolead.org/. In the
main page, the user can click any of the human chromo-
somes underneath the introduction text to obtain a list of
all CR events related to the chromosome. This list can be
sorted by Event ID, Karyotype, Precision code, Case ID
or Disease name by clicking any of these attribute names.
The user can click an Event ID to display the ‘detailed
information’ about this event. On the top of the ‘detailed
information’ page is the name of the disease associated
with this event, the DOID of the disease, and a link to
the corresponding disease in the Ontology Lookup Service
(OLS) (20). The user can obtain a list of all events
associated with this disease by clicking the link labeled
‘All events related to this disease’. The information
about the CR event, including the precision code, event
type, chromosome and karyotype and breakpoint infor-
mation is displayed below. The junction sequences (when
available), the types of the junction sequences (‘con-
ﬁrmed’, ‘reported’ or ‘inferred’), the experimental tech-
niques applied to identify/analyze the CR events, as well
as the reference to the original study are provided below.
On the bottom of the ‘detailed information’ page is a
reduced-size genome browser image. The user can click
this image to access the genome browser view of the CR
event (described below).
The user can click the ‘Search’ tab below the dbCRID
project logo to reach the ‘event search page’. This page
allows the user to search CR events by chromosome,
chromosome arm, CR type, by the gene involved (using
a RefSeq accession), and by the name of an author or a
keyword of the original study. The list of CR events
returned by the search function is of the same format as
the CR event list for individual chromosomes (described
above), with links to ‘detailed information’ pages of the
events listed.
The ‘Disease List’ tab below the dbCRID project logo
allows the user to view the entire list of diseases associated
with any CR events documented in dbCRID, displayed in
a hierarchical order based on the DOID structure. The
user can click any of the disease names to view a list of
cases and related events associated with the disease of
interest.
The ‘Genome Browser’ tab below the project logo
allows the user to view the CR events in the browser
mode. The user can specify the chromosome and region
of interest, or select a region of interest using by mouse
operations, and the browser will display all CR events (or
the ones of selected types) occurring in the selected
regions. Mouse-over a region with a CR event in the
browser will trigger the display of a schematic graph
that intuitively presents the CR event. Information
about known RefSeq genes in the region is also displayed.
Optionally, the user can upload his/her own track ﬁles
that contain other types of data for comparison purposes.
The ‘Download’ tab below the project logo points to a
data download page, where the current release of the
entire dataset can be downloaded as a tab-delimited text
ﬁle.
The ‘Glossary’ tab below the project logo points to the
glossary page where terms and abbreviations used in the
web site are explained.
Data access
The dbCRID web site is publicly accessible through the
URL http://dbCRID.biolead.org/. The current released
dataset can be downloaded from the web site.
Additional requests can be made by emailing to
dbCRID@biolead.org.
Implementation
dbCRID was constructed as a relational database imple-
mented with MySQL on a Fedora Core 10 Linux system.
The front-end web interface was implemented as a PHP
project (enhanced with JavaScript) running under Apache
2.0. The Genome Browser function was implemented
using Gbrowse 2.0 (21).
COMPARISON WITH RELATED DATABASES
dbCRID is a new, comprehensive database of human CR
events and associated diseases (both tumor and
non-tumor) with detailed documentation of the CR
events—including precise breakpoint positions and
junction sequences—for all seven types of CR events. A
comparison with related databases demonstrates the
unique features of this new resource (Table 1).
Atlas of Genetics and Cytogenetics in Oncology and
Haematology (22) is an integrative database of human
cancers, cancer-prone diseases and involved genes. For a
given cancer type, the breakpoints of related CR events
can be inferred from the hybrid genes or chromosomal
aberrations listed. ChimerDB (1.0 & 2.0) is a
knowledgebase for fusion genes (23). Transcript sequences
were obtained and integrated from Genbank and other
public resources. Fusion genes resulting from
interchromosomal translocations, intrachromosomal dele-
tions or inversions are classiﬁed in ChimerDB 2.0. The
breakpoints on the genes can be viewed in the custom
genome browser viewer. CytoD 1.0 (Cytogenetics
Database, http://www.changbioscience.com/cytogenetics/
cyto.htm) is a large database of literature abstracts of
reported cytogenetic abnormalities. It does not provide
detailed information about the breakpoints or the junc-
tions, nor does it provide any information about related
diseases or experimental techniques applied. DARCO
(https://www1.hgu.mrc.ac.uk/Softdata/Translocation/) is
an unpublished database of CR events and associated
abnormal phenotypes that focuses mainly on transloca-
tion events. Breakpoint locations are provided on chromo-
somal region level (equivalent to precision code ‘C’ in
dbCRID), and no information about disrupted genes,
junction sequences or experimental techniques applied is
provided. Decipher (24) is a database of chromosomal
imbalance, inversion and translocation events (derived
from array CGH data) and associated symptoms/pheno-
types. The chromosomal locations of submicroscopic copy
number changes—mainly microdeletion and
microduplications—as well as the genes involved can be
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HYBRIDdb (25), like ChimerDB, is a database of hybrid
genes in human genome. More than 1000 genes pairs re-
sulting from chromosome translocation were identiﬁed,
and the breakpoint on each gene was located. The
Mitelman Database of Chromosome Aberrations and
Gene Fusions in Cancer (http://cgap.nci.nih.gov/
Chromosomes/Mitelman) is a popular database of
chromosomal aberrations in human tumors and
associated genes. Karyotype abnormalities associated
with a particular tumor can be searched through the
Cases Searchers. Gene rearrangements resulting from
cytogenetic aberrations can be searched through the
Molecular Biology Associations Searcher. The Recurrent
Chromosome Aberrations Searcher allows the searching
of recurrent aberrations in speciﬁc tumors. Moreover, the
Clinical Associations Searcher allows the searching of as-
sociations between cytogenetic aberrations and/or gene
rearrangements and tumor characteristics. Currently,
2044 CR events clinically associated with cancers are
documented in the Mitelman Database. The SKY/
M-FISH & CGH database (26) is a database of molecular
cytogenetics data from SKY/M-FISH or CGH studies in
human cancers. As with the Mitelman Database, it focuses
on CR events associated with tumors only, and the
detailed information about the breakpoints (e.g. their
precise locations, disrupted genes, or junction sequences)
is not provided. TICdb (27) is database of fusion genes
resulting from reciprocal translocation events associated
with tumors. It documents the precise location of each
breakpoint inside a fusion gene, but does not map the
breakpoints to the genome.
In summary, each of these existing databases has its
distinct strengths and values. Compared to these resources,
dbCRID is the only database that (i) documents CR events
associated with both tumor and non-tumor diseases,
(ii) covers all seven types of CR events, (iii) provides break-
point position information in three different precision
levels,(iv)providesdetailedjunctionsequenceinformation,
(v) documents experimental methods applied in original
studies, (vi) provides detailed information about disrupted
genes and gene regions and (vii) provides an intuitive
browser view for examining the CR events.
FUTURE DIRECTIONS
The development and release of the current version of
dbCRID marks an important ﬁrst step towards our
long-term goal. Our next-step plans include: (i) we will
continue and expand the dbCRID curation effort as pub-
lished studies on CR events and associated diseases accu-
mulate. The advances in new experimental techniques and
strategies, especially in deep sequencing technologies will
lead to accelerated accumulation of interesting data (28).
Large-scale sequencing projects, in particular, the Cancer
Genome Project (29,30) will continue to feed important
data to the curation effort. (ii) We will try to identify
potential genomic architecture features, e.g. CpG island,
low copy repeats which may contribute to CR susceptibil-
ity. (iii) We will investigate patterns in disrupted genes,
gene clusters or pathways and their potential associations
with disease etiology. (iv) We will develop and improve
methods for identifying and analyzing junction sequence
features critical for disease mechanisms (31).
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